Search details
1.
Safety and immunogenicity of the H56:IC31 tuberculosis vaccine candidate in adults successfully treated for drug-susceptible pulmonary TB: a phase 1 randomized trial.
J Infect Dis
; 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38557639
2.
Twice-Daily Dolutegravir Based Antiretroviral Therapy with One Month of Daily Rifapentine and Isoniazid (1HP) for TB Prevention.
Clin Infect Dis
; 2024 Apr 03.
Article
in English
| MEDLINE | ID: mdl-38568956
3.
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
Clin Infect Dis
; 78(6): 1680-1689, 2024 Jun 14.
Article
in English
| MEDLINE | ID: mdl-38462673
4.
Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
Clin Infect Dis
; 2024 May 13.
Article
in English
| MEDLINE | ID: mdl-38739755
5.
High rifampicin peak plasma concentrations accelerate the slow phase of bacterial decline in tuberculosis patients: Evidence for heteroresistance.
PLoS Comput Biol
; 19(4): e1011000, 2023 04.
Article
in English
| MEDLINE | ID: mdl-37053266
6.
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results.
Am J Respir Crit Care Med
; 207(7): 929-935, 2023 04 01.
Article
in English
| MEDLINE | ID: mdl-36455068
7.
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.
Am J Respir Crit Care Med
; 207(10): 1376-1382, 2023 05 15.
Article
in English
| MEDLINE | ID: mdl-36790881
8.
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).
Clin Infect Dis
; 76(3): e580-e589, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-36041016
9.
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis.
Clin Infect Dis
; 77(6): 892-900, 2023 09 18.
Article
in English
| MEDLINE | ID: mdl-37227925
10.
Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832.
Antimicrob Agents Chemother
; 67(6): e0147722, 2023 06 15.
Article
in English
| MEDLINE | ID: mdl-37219453
11.
Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis.
Antimicrob Agents Chemother
; 67(10): e0068323, 2023 10 18.
Article
in English
| MEDLINE | ID: mdl-37768317
12.
Effect of Clofazimine Concentration on QT Prolongation in Patients Treated for Tuberculosis.
Antimicrob Agents Chemother
; 65(7): e0268720, 2021 06 17.
Article
in English
| MEDLINE | ID: mdl-33875426
13.
Pretomanid Pharmacokinetics in the Presence of Rifamycins: Interim Results from a Randomized Trial among Patients with Tuberculosis.
Antimicrob Agents Chemother
; 65(2)2021 01 20.
Article
in English
| MEDLINE | ID: mdl-33229425
14.
Increased bactericidal activity but dose-limiting intolerability at 50â mg·kg-1 rifampicin.
Eur Respir J
; 58(1)2021 07.
Article
in English
| MEDLINE | ID: mdl-33542056
15.
Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial.
J Infect Dis
; 222(Suppl 1): S63-S69, 2020 07 09.
Article
in English
| MEDLINE | ID: mdl-32645158
16.
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.
Clin Infect Dis
; 70(3): 436-445, 2020 01 16.
Article
in English
| MEDLINE | ID: mdl-30919881
17.
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.
Clin Infect Dis
; 70(3): 425-435, 2020 01 16.
Article
in English
| MEDLINE | ID: mdl-30942853
18.
Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Article
in English
| MEDLINE | ID: mdl-31988102
19.
Clofazimine pharmacokinetics in patients with TB: dosing implications.
J Antimicrob Chemother
; 75(11): 3269-3277, 2020 11 01.
Article
in English
| MEDLINE | ID: mdl-32747933
20.
A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine.
Antimicrob Agents Chemother
; 63(4)2019 04.
Article
in English
| MEDLINE | ID: mdl-30670438